Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.

Manon RedaPauline MacaireHélène BellioLionel UwerSilvia IlieVéronique LorgisAudrey HennequinSylvain LadoireEmilie RederstorffPierre FumoleauNicolas IsambertNathalie BonninBenoit YouGilles FreyerIsabelle DesmoulinsAntonin Schmitt

Published in: Cancer chemotherapy and pharmacology (2022)

Eudract 2015-001753-32, 2015/01/26.

Keyphrases

metastatic breast cancer
phase ii
clinical trial
cerebrospinal fluid
double blind